Skip to main content
CNTAHealthcare

Centessa Pharmaceuticals plc ADR (CNTA) Insider Trading

In the last 90 days, no Centessa Pharmaceuticals plc ADR (CNTA) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 24, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 24, 2026Medicxi Growth I LP10% OwnerSale19,963,157$0.00$0.00
Jun 24, 2026Medicxi Growth Co-Invest I LP10% OwnerSale19,963,157$0.00$0.00
Jun 24, 2026Medicxi Ventures Management (Jersey) Ltd10% OwnerSale19,963,157$0.00$0.00
Jun 24, 2026Medicxi Growth I GP Ltd10% OwnerSale19,963,157$0.00$0.00
Jun 24, 2026Medicxi Ventures I GP Ltd10% OwnerSale19,963,157$0.00$0.00
Jun 24, 2026Medicxi Ventures I LP10% OwnerSale19,963,157$0.00$0.00
Jun 24, 2026Medicxi Co-Invest I LP10% OwnerSale19,963,157$0.00$0.00
Jun 24, 2026Medicxi Secondary I LP10% OwnerSale19,963,157$0.00$0.00
Jun 24, 2026Medicxi Secondary I GP Ltd.10% OwnerSale19,963,157$0.00$0.00
Jun 24, 2026Medicxi Secondary Co-Invest I LP10% OwnerSale19,963,157$0.00$0.00

Common questions

CNTA insider trading FAQ

Are CNTA insiders buying or selling?
No CNTA insiders reported open-market purchases or sales in the last 90 days.
When was the last CNTA insider purchase?
No open-market insider purchase of Centessa Pharmaceuticals plc ADR stock was reported in the last 90 days.
Where does CNTA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Centessa Pharmaceuticals plc ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.